Motif ID: Elf1_Elf2_Etv2_Elf4
Z-value: 2.516
Transcription factors associated with Elf1_Elf2_Etv2_Elf4:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Elf1 | ENSMUSG00000036461.9 | Elf1 |
| Elf2 | ENSMUSG00000037174.12 | Elf2 |
| Elf4 | ENSMUSG00000031103.6 | Elf4 |
| Etv2 | ENSMUSG00000006311.8 | Etv2 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Elf1 | mm10_v2_chr14_+_79515618_79515694 | 0.37 | 5.7e-03 | Click! |
| Elf2 | mm10_v2_chr3_-_51340628_51340681 | -0.21 | 1.3e-01 | Click! |
| Elf4 | mm10_v2_chrX_-_48454152_48454193 | -0.04 | 7.5e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.1 | 40.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 9.2 | 27.6 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 7.3 | 29.0 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 7.2 | 21.6 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 7.0 | 20.9 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 5.0 | 19.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 4.3 | 25.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 4.0 | 39.6 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 3.8 | 23.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 3.8 | 26.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 3.8 | 3.8 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
| 3.7 | 11.1 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 3.6 | 14.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 3.6 | 21.9 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 3.6 | 10.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 3.6 | 10.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 3.5 | 10.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
| 3.3 | 13.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 3.3 | 13.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 3.2 | 9.5 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 3.2 | 12.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 3.1 | 9.2 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 3.0 | 6.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 3.0 | 18.0 | GO:0046070 | dGTP metabolic process(GO:0046070) |
| 3.0 | 14.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 3.0 | 20.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 2.9 | 8.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 2.8 | 2.8 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 2.8 | 11.3 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 2.8 | 8.4 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 2.7 | 13.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 2.7 | 13.5 | GO:1990839 | response to endothelin(GO:1990839) |
| 2.7 | 10.8 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 2.7 | 13.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 2.7 | 8.1 | GO:1990046 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 2.6 | 2.6 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 2.6 | 13.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 2.6 | 10.5 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 2.6 | 5.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 2.6 | 43.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 2.5 | 7.6 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil activation(GO:1902566) |
| 2.5 | 7.6 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 2.5 | 2.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 2.4 | 24.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 2.4 | 33.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 2.3 | 13.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 2.3 | 6.9 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 2.3 | 11.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 2.3 | 20.3 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 2.2 | 15.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 2.2 | 6.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 2.2 | 10.9 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 2.2 | 6.5 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 2.2 | 6.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 2.1 | 6.4 | GO:0046544 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) development of secondary male sexual characteristics(GO:0046544) |
| 2.1 | 6.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 2.1 | 2.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 2.0 | 10.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 2.0 | 2.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 2.0 | 18.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 2.0 | 8.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 2.0 | 7.9 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 2.0 | 66.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 1.9 | 7.8 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 1.9 | 3.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
| 1.9 | 13.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 1.9 | 7.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 1.9 | 15.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.9 | 1.9 | GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
| 1.9 | 5.6 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.9 | 9.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 1.9 | 5.6 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 1.9 | 5.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 1.8 | 5.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 1.8 | 1.8 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 1.8 | 16.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.8 | 7.3 | GO:0006272 | leading strand elongation(GO:0006272) |
| 1.8 | 10.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 1.8 | 1.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.8 | 1.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 1.8 | 5.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.8 | 16.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 1.8 | 7.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 1.8 | 7.1 | GO:0030576 | Cajal body organization(GO:0030576) |
| 1.8 | 14.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 1.8 | 3.5 | GO:0000237 | leptotene(GO:0000237) |
| 1.8 | 7.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 1.8 | 3.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 1.7 | 10.5 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.7 | 6.9 | GO:1903416 | response to glycoside(GO:1903416) |
| 1.7 | 1.7 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
| 1.7 | 5.1 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 1.7 | 5.1 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 1.7 | 5.0 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 1.7 | 8.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 1.7 | 21.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 1.7 | 11.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 1.7 | 5.0 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 1.6 | 6.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 1.6 | 6.6 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.6 | 3.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 1.6 | 4.9 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 1.6 | 4.9 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
| 1.6 | 6.5 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 1.6 | 1.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 1.6 | 44.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 1.6 | 1.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 1.6 | 6.3 | GO:0048478 | replication fork protection(GO:0048478) |
| 1.6 | 10.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 1.5 | 3.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.5 | 4.6 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 1.5 | 10.8 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 1.5 | 15.3 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 1.5 | 4.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 1.5 | 34.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 1.5 | 6.0 | GO:0001302 | replicative cell aging(GO:0001302) |
| 1.5 | 33.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 1.5 | 6.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 1.5 | 1.5 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 1.5 | 4.5 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 1.5 | 4.5 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 1.5 | 3.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.5 | 8.9 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 1.5 | 13.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 1.5 | 16.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 1.4 | 7.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 1.4 | 10.1 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.4 | 14.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 1.4 | 1.4 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 1.4 | 11.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 1.4 | 11.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.4 | 4.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 1.4 | 5.7 | GO:1902724 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.4 | 2.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 1.4 | 2.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 1.4 | 4.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 1.4 | 5.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 1.4 | 2.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 1.4 | 5.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 1.4 | 8.2 | GO:0015074 | DNA integration(GO:0015074) |
| 1.4 | 15.0 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 1.4 | 4.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 1.4 | 4.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
| 1.4 | 12.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 1.3 | 2.7 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 1.3 | 8.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 1.3 | 4.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 1.3 | 3.9 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
| 1.3 | 35.2 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 1.3 | 3.9 | GO:1901355 | response to rapamycin(GO:1901355) |
| 1.3 | 19.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 1.3 | 2.6 | GO:0061511 | centriole elongation(GO:0061511) |
| 1.3 | 11.5 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 1.3 | 22.9 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 1.3 | 1.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 1.3 | 11.4 | GO:0001842 | neural fold formation(GO:0001842) |
| 1.3 | 1.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 1.3 | 1.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 1.3 | 7.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 1.3 | 2.5 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 1.3 | 3.8 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 1.3 | 5.0 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 1.2 | 13.7 | GO:0060539 | diaphragm development(GO:0060539) |
| 1.2 | 7.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 1.2 | 1.2 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
| 1.2 | 14.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 1.2 | 1.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 1.2 | 31.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 1.2 | 7.3 | GO:0044351 | macropinocytosis(GO:0044351) |
| 1.2 | 6.0 | GO:0010273 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
| 1.2 | 4.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 1.2 | 7.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 1.2 | 10.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 1.2 | 1.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 1.2 | 2.4 | GO:0051026 | chiasma assembly(GO:0051026) |
| 1.2 | 7.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 1.2 | 5.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 1.2 | 3.5 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 1.2 | 3.5 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 1.2 | 3.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 1.2 | 2.3 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 1.1 | 3.4 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 1.1 | 1.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 1.1 | 9.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
| 1.1 | 6.7 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.1 | 3.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.1 | 26.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 1.1 | 10.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 1.1 | 19.8 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 1.1 | 2.2 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.1 | 2.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 1.1 | 2.2 | GO:0014891 | striated muscle atrophy(GO:0014891) |
| 1.1 | 5.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 1.1 | 21.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 1.1 | 10.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 1.1 | 8.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
| 1.1 | 6.4 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
| 1.1 | 9.6 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 1.1 | 4.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 1.1 | 3.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
| 1.1 | 7.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 1.1 | 4.3 | GO:0015889 | cobalamin transport(GO:0015889) |
| 1.1 | 3.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 1.1 | 4.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 1.1 | 2.1 | GO:0002762 | negative regulation of myeloid leukocyte differentiation(GO:0002762) negative regulation of osteoclast differentiation(GO:0045671) |
| 1.1 | 1.1 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.1 | 5.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 1.0 | 4.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 1.0 | 3.1 | GO:0015867 | ATP transport(GO:0015867) |
| 1.0 | 1.0 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
| 1.0 | 4.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 1.0 | 15.4 | GO:0051451 | myoblast migration(GO:0051451) |
| 1.0 | 3.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
| 1.0 | 13.3 | GO:0043486 | histone exchange(GO:0043486) |
| 1.0 | 3.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 1.0 | 3.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 1.0 | 37.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 1.0 | 6.0 | GO:0021539 | subthalamus development(GO:0021539) |
| 1.0 | 4.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 1.0 | 3.0 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 1.0 | 3.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 1.0 | 4.9 | GO:1903232 | melanosome assembly(GO:1903232) |
| 1.0 | 2.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
| 1.0 | 3.9 | GO:0032382 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
| 1.0 | 4.8 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 1.0 | 1.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.0 | 2.9 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.9 | 3.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.9 | 9.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.9 | 0.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.9 | 3.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.9 | 2.8 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.9 | 2.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.9 | 10.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.9 | 4.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.9 | 2.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.9 | 3.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.9 | 2.7 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.9 | 0.9 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.9 | 2.7 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.9 | 9.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.9 | 3.6 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.9 | 6.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.9 | 1.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.9 | 8.8 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
| 0.9 | 6.1 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.9 | 7.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.9 | 5.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.9 | 3.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.9 | 0.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.9 | 3.5 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.9 | 1.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.9 | 4.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.9 | 3.5 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.9 | 6.9 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.9 | 4.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 0.9 | 0.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.9 | 4.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.9 | 6.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.9 | 2.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.9 | 14.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.8 | 3.4 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.8 | 0.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
| 0.8 | 15.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.8 | 3.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.8 | 4.2 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.8 | 5.8 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.8 | 4.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.8 | 9.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.8 | 1.7 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.8 | 1.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.8 | 2.5 | GO:1904395 | synaptic growth at neuromuscular junction(GO:0051124) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.8 | 2.5 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.8 | 1.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.8 | 36.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.8 | 3.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.8 | 3.2 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.8 | 1.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 0.8 | 6.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.8 | 4.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.8 | 3.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.8 | 4.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.8 | 1.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.8 | 8.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.8 | 1.6 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.8 | 0.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.8 | 21.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 0.8 | 2.3 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.8 | 1.6 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.8 | 5.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 0.8 | 2.3 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.8 | 3.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.8 | 6.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.8 | 2.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.8 | 19.1 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.8 | 2.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.8 | 3.0 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.8 | 28.8 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.8 | 2.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.8 | 3.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.8 | 20.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.8 | 6.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.8 | 3.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.8 | 6.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.8 | 2.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.7 | 0.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.7 | 2.2 | GO:0031424 | keratinization(GO:0031424) |
| 0.7 | 1.5 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
| 0.7 | 2.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.7 | 2.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 0.7 | 3.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.7 | 1.5 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.7 | 2.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.7 | 1.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.7 | 1.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.7 | 2.2 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.7 | 2.9 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.7 | 2.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.7 | 3.6 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.7 | 5.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.7 | 2.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.7 | 9.2 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.7 | 2.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.7 | 2.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.7 | 0.7 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.7 | 2.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.7 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.7 | 4.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.7 | 2.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.7 | 1.4 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.7 | 2.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.7 | 0.7 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.7 | 2.1 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.7 | 2.7 | GO:0030091 | protein repair(GO:0030091) |
| 0.7 | 2.7 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.7 | 0.7 | GO:0090148 | membrane fission(GO:0090148) |
| 0.7 | 0.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.7 | 2.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.7 | 1.4 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.7 | 5.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.7 | 0.7 | GO:0070989 | oxidative demethylation(GO:0070989) |
| 0.7 | 2.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.7 | 2.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.7 | 4.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.7 | 2.7 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.7 | 2.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.7 | 2.6 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.7 | 6.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.7 | 2.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.7 | 3.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.7 | 0.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.7 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.7 | 0.7 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 0.7 | 12.4 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.7 | 0.7 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
| 0.7 | 9.1 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.6 | 2.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.6 | 1.3 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.6 | 0.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.6 | 1.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.6 | 5.1 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.6 | 5.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.6 | 1.3 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.6 | 3.8 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.6 | 3.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.6 | 1.9 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
| 0.6 | 7.5 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.6 | 1.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 | 1.2 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.6 | 1.8 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.6 | 1.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.6 | 1.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.6 | 2.4 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.6 | 2.4 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.6 | 3.0 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.6 | 6.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.6 | 2.4 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.6 | 4.8 | GO:0006560 | proline metabolic process(GO:0006560) |
| 0.6 | 2.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.6 | 4.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.6 | 16.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.6 | 13.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.6 | 0.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.6 | 1.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.6 | 0.6 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.6 | 0.6 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.6 | 8.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.6 | 2.3 | GO:0048864 | stem cell development(GO:0048864) |
| 0.6 | 2.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.6 | 10.4 | GO:0000303 | response to superoxide(GO:0000303) |
| 0.6 | 1.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.6 | 1.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.6 | 1.7 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 0.6 | 1.1 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
| 0.6 | 2.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.6 | 2.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.6 | 2.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.6 | 1.7 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.5 | 1.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.5 | 1.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.5 | 2.7 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.5 | 5.4 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.5 | 0.5 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
| 0.5 | 2.2 | GO:0061743 | motor learning(GO:0061743) |
| 0.5 | 2.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.5 | 1.6 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
| 0.5 | 5.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.5 | 1.6 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.5 | 1.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 | 5.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.5 | 1.1 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
| 0.5 | 0.5 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.5 | 5.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.5 | 2.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.5 | 3.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.5 | 3.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.5 | 2.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.5 | 7.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.5 | 0.5 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.5 | 0.5 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
| 0.5 | 3.6 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.5 | 1.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.5 | 4.1 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.5 | 0.5 | GO:1903204 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.5 | 4.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.5 | 2.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.5 | 0.5 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.5 | 12.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.5 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.5 | 1.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
| 0.5 | 1.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.5 | 0.5 | GO:0080144 | amino acid homeostasis(GO:0080144) |
| 0.5 | 2.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.5 | 0.5 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 1.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.5 | 2.5 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.5 | 4.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.5 | 6.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.5 | 2.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.5 | 6.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.5 | 1.5 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.5 | 0.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.5 | 6.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.5 | 3.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.5 | 1.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.5 | 1.4 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.5 | 1.9 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.5 | 6.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.5 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.5 | 0.9 | GO:0010248 | B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.5 | 1.4 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.5 | 7.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.5 | 0.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.5 | 1.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.5 | 4.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.5 | 0.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.5 | 0.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.5 | 9.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.5 | 5.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.5 | 8.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.5 | 0.9 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.5 | 0.5 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.5 | 1.4 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.5 | 8.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.5 | 141.3 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.5 | 1.4 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
| 0.5 | 5.9 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) |
| 0.5 | 1.8 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.5 | 14.6 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.5 | 1.4 | GO:0003339 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.5 | 2.3 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 0.5 | 0.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.5 | 0.5 | GO:0051785 | positive regulation of mitotic nuclear division(GO:0045840) positive regulation of nuclear division(GO:0051785) |
| 0.4 | 2.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.4 | 2.7 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
| 0.4 | 2.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.4 | 0.9 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.4 | 3.5 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.4 | 2.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.4 | 18.8 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.4 | 13.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.4 | 1.3 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.4 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.4 | 2.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.4 | 1.7 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.4 | 4.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.4 | 2.6 | GO:0021830 | substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.4 | 1.7 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.4 | 0.4 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
| 0.4 | 6.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.4 | 3.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.4 | 7.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.4 | 2.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.4 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.4 | 0.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.4 | 1.3 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.4 | 4.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.4 | 2.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.4 | 5.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.4 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.4 | 3.3 | GO:1904707 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.4 | 4.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.4 | 2.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.4 | 1.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.4 | 2.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.4 | 2.1 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.4 | 0.8 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.4 | 2.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.4 | 2.4 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.4 | 1.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.4 | 1.6 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.4 | 3.6 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.4 | 2.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.4 | 2.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.4 | 4.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.4 | 2.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.4 | 2.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.4 | 1.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 | 1.6 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.4 | 9.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.4 | 0.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.4 | 3.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.4 | 2.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.4 | 1.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.4 | 4.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.4 | 6.1 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.4 | 0.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.4 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.4 | 1.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.4 | 0.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.4 | 0.4 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
| 0.4 | 0.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.4 | 1.5 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
| 0.4 | 3.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.4 | 0.4 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.4 | 3.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.4 | 3.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 | 0.4 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.4 | 2.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.4 | 1.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.4 | 0.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.4 | 5.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.4 | 2.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.4 | 4.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.4 | 1.1 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.4 | 7.0 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.4 | 1.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.4 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.4 | 1.1 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.4 | 0.7 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.4 | 0.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
| 0.4 | 0.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.4 | 16.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.4 | 4.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.4 | 1.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.4 | 12.4 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.4 | 0.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.4 | 1.8 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
| 0.4 | 1.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
| 0.4 | 5.0 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.4 | 1.1 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
| 0.4 | 1.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.4 | 1.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.4 | 2.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.4 | 0.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.3 | 1.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.3 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 0.3 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
| 0.3 | 2.4 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.3 | 3.8 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.3 | 1.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 | 1.7 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.3 | 1.0 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.3 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.3 | 1.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.3 | 1.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.3 | 3.0 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.3 | 3.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.3 | 3.7 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
| 0.3 | 1.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.3 | 0.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.3 | 1.0 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.3 | 3.7 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.3 | 1.3 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
| 0.3 | 1.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.3 | 1.0 | GO:1902866 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) regulation of amacrine cell differentiation(GO:1902869) |
| 0.3 | 0.3 | GO:0035384 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) thioester biosynthetic process(GO:0035384) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) acyl-CoA biosynthetic process(GO:0071616) |
| 0.3 | 5.8 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.3 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.3 | 6.4 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
| 0.3 | 1.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.3 | 5.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.3 | 1.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.3 | 0.6 | GO:0022616 | DNA strand elongation(GO:0022616) |
| 0.3 | 1.6 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 0.3 | 1.0 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.3 | 0.3 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.3 | 1.0 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 | 1.3 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.3 | 0.3 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.3 | 0.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
| 0.3 | 2.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.3 | 3.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.3 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 | 4.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.3 | 2.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.3 | 1.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.3 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 | 0.9 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.3 | 0.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.3 | 5.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.3 | 4.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.3 | 2.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.3 | 1.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.3 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.3 | 5.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 | 0.9 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.3 | 1.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.3 | 0.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.3 | 0.9 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 | 1.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 1.7 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.3 | 4.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.3 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.3 | 1.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.3 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.3 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 | 2.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.3 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 | 4.8 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.3 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.3 | 0.3 | GO:0044772 | mitotic cell cycle phase transition(GO:0044772) |
| 0.3 | 2.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 | 4.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.3 | 0.5 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.3 | 5.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.3 | 3.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.3 | 0.5 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
| 0.3 | 0.8 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
| 0.3 | 0.8 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
| 0.3 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.3 | 1.1 | GO:0015786 | UDP-glucose transport(GO:0015786) |
| 0.3 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.3 | 2.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.3 | 1.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.3 | 4.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.3 | 0.5 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.3 | 0.3 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
| 0.3 | 0.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.3 | 1.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.3 | 1.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 | 1.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 1.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.3 | 2.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.3 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.3 | 2.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.3 | 0.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.3 | 6.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.3 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.3 | 1.3 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.3 | 1.8 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.3 | 2.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.3 | 1.0 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.3 | 2.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 | 1.8 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.3 | 5.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.3 | 1.0 | GO:0035878 | nail development(GO:0035878) |
| 0.3 | 0.8 | GO:0019405 | alditol catabolic process(GO:0019405) |
| 0.2 | 1.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.2 | 2.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.2 | 0.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.2 | 1.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 | 0.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.2 | 1.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 2.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.2 | 2.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.2 | 0.5 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.2 | 17.2 | GO:0006413 | translational initiation(GO:0006413) |
| 0.2 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.2 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 | 0.7 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 2.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.2 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 1.4 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 | 1.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.2 | 0.2 | GO:0033122 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.2 | 0.9 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.2 | 1.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.2 | 0.7 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.2 | 0.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 | 0.5 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.2 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 | 1.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.2 | 1.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.2 | 1.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.2 | 0.9 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.2 | 1.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.2 | 1.3 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 | 2.9 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 0.2 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.2 | 1.8 | GO:0051604 | protein maturation(GO:0051604) |
| 0.2 | 1.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 5.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.2 | 2.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.2 | 1.1 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.2 | 0.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 | 0.9 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.2 | 5.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 | 3.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.2 | 4.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 | 7.0 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.2 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.2 | 1.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.2 | 2.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.2 | 1.5 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.2 | 0.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.2 | 0.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.2 | 2.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 | 1.0 | GO:0007320 | insemination(GO:0007320) |
| 0.2 | 0.4 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 | 1.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.2 | 0.4 | GO:0009838 | abscission(GO:0009838) |
| 0.2 | 1.4 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.2 | 26.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.2 | 9.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.2 | 0.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 | 1.4 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.2 | 1.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.2 | 2.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 | 0.2 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.2 | 1.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 | 2.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.2 | 0.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 | 4.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.2 | 1.6 | GO:1901991 | negative regulation of mitotic cell cycle phase transition(GO:1901991) |
| 0.2 | 1.2 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.2 | 0.2 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.2 | 1.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.2 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.2 | 11.9 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.2 | 1.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 0.9 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.2 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.2 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.2 | 0.4 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 | 0.2 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) |
| 0.2 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 0.4 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.2 | 0.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.2 | 0.2 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
| 0.2 | 1.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.2 | 2.3 | GO:0021510 | spinal cord development(GO:0021510) |
| 0.2 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
| 0.2 | 3.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.2 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.2 | 0.5 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.2 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.2 | 1.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 0.3 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
| 0.2 | 0.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.2 | 1.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.2 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 5.1 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.2 | 3.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.2 | 1.8 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.2 | 2.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.2 | 1.5 | GO:1902686 | mitochondrial outer membrane permeabilization(GO:0097345) positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
| 0.2 | 0.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 0.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.2 | 1.1 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
| 0.2 | 6.5 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.2 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.2 | 2.4 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.2 | 1.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 | 0.3 | GO:0015675 | nickel cation transport(GO:0015675) |
| 0.2 | 2.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.2 | 0.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.2 | 1.1 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.2 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 0.2 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
| 0.2 | 0.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.2 | 1.7 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.2 | 0.2 | GO:0045780 | positive regulation of tissue remodeling(GO:0034105) positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.2 | 4.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.2 | 0.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 | 4.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.2 | 0.9 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
| 0.2 | 0.3 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
| 0.2 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.4 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 | 14.1 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.1 | 0.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 1.3 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.6 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 0.4 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.1 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.1 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.1 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 2.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 3.9 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 0.6 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.1 | 7.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.9 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 | 0.9 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 | 1.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
| 0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 0.7 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 | 3.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 1.0 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 0.3 | GO:0061551 | cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) |
| 0.1 | 0.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 4.7 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.1 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.1 | 2.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 0.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 | 1.4 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
| 0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 | 0.1 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
| 0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
| 0.1 | 0.9 | GO:0036344 | platelet morphogenesis(GO:0036344) |
| 0.1 | 0.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.1 | 5.6 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 | 0.9 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.1 | 2.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.6 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 | 0.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 | 0.5 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.1 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.1 | 1.9 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
| 0.1 | 1.2 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
| 0.1 | 0.4 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.1 | 0.4 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 | 0.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.6 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
| 0.1 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 0.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
| 0.1 | 0.6 | GO:0006534 | cysteine metabolic process(GO:0006534) |
| 0.1 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.1 | 0.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 | 0.4 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 0.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 | 2.1 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 | 1.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
| 0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 1.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 | 0.6 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.7 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.1 | 0.6 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.1 | 0.3 | GO:0060948 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.1 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 | 2.1 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 0.1 | 0.2 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 2.0 | GO:0007098 | centrosome cycle(GO:0007098) |
| 0.1 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 1.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 | 0.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 | 0.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 | 0.7 | GO:0048535 | lymph node development(GO:0048535) |
| 0.1 | 0.5 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 | 0.3 | GO:0043631 | mRNA polyadenylation(GO:0006378) mRNA 3'-end processing(GO:0031124) RNA polyadenylation(GO:0043631) |
| 0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 | 0.3 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 | 1.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 1.9 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
| 0.1 | 0.6 | GO:0060674 | placenta blood vessel development(GO:0060674) labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 1.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.1 | 0.9 | GO:0061180 | mammary gland epithelium development(GO:0061180) |
| 0.1 | 0.7 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.2 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.1 | 0.2 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.1 | 0.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 2.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.1 | 0.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 0.1 | 0.9 | GO:0070203 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) |
| 0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.1 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.1 | 0.6 | GO:0045862 | positive regulation of proteolysis(GO:0045862) |
| 0.1 | 0.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 | 0.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.8 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 | 0.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 | 0.3 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.1 | 0.4 | GO:0015819 | lysine transport(GO:0015819) |
| 0.1 | 1.2 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.9 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 1.1 | GO:0009409 | response to cold(GO:0009409) |
| 0.1 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 | 1.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.1 | 2.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 | 0.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 | 0.5 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.1 | 0.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
| 0.1 | 2.0 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
| 0.1 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 | 0.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.6 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
| 0.1 | 1.4 | GO:0007588 | excretion(GO:0007588) |
| 0.1 | 2.4 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 0.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 1.4 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
| 0.1 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.3 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.1 | 0.4 | GO:0072593 | reactive oxygen species metabolic process(GO:0072593) |
| 0.1 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 4.4 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.1 | 0.3 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
| 0.1 | 0.2 | GO:0048255 | mRNA stabilization(GO:0048255) |
| 0.1 | 0.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.1 | 0.4 | GO:0046189 | phenol-containing compound metabolic process(GO:0018958) phenol-containing compound biosynthetic process(GO:0046189) |
| 0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.2 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.1 | 1.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 2.1 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.1 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) urea transport(GO:0015840) |
| 0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.1 | 0.2 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
| 0.1 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 | 0.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.1 | 0.3 | GO:0016125 | sterol metabolic process(GO:0016125) |
| 0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 0.3 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
| 0.1 | 1.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.1 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.1 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 0.1 | GO:0003188 | heart valve formation(GO:0003188) |
| 0.0 | 0.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.0 | 0.4 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
| 0.0 | 0.6 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.0 | 0.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.0 | 0.8 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
| 0.0 | 0.5 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.0 | 0.0 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 | 0.1 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.0 | 0.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 | 1.4 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.0 | 0.1 | GO:0006001 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.0 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.0 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) regulation of defense response to fungus(GO:1900150) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.0 | 0.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.0 | 0.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.0 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.0 | 0.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.0 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.8 | GO:0032608 | interferon-beta production(GO:0032608) |
| 0.0 | 0.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.0 | 0.4 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 | 0.2 | GO:0042089 | cytokine biosynthetic process(GO:0042089) cytokine metabolic process(GO:0042107) |
| 0.0 | 0.5 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 | 1.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 0.0 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.0 | 0.3 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 | 0.3 | GO:0048599 | oocyte development(GO:0048599) |
| 0.0 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 | 0.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 | 0.0 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) |
| 0.0 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.0 | 0.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.3 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.0 | 1.8 | GO:0007059 | chromosome segregation(GO:0007059) |
| 0.0 | 0.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 0.0 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
| 0.0 | 0.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.0 | 0.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 | 0.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.0 | 0.1 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.0 | 0.0 | GO:0046051 | UTP metabolic process(GO:0046051) |
| 0.0 | 0.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.0 | 0.5 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.0 | 2.8 | GO:0006412 | translation(GO:0006412) |
| 0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 | 0.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.0 | 0.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 | 0.1 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
| 0.0 | 0.0 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.3 | 24.9 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 6.0 | 18.0 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 5.2 | 15.6 | GO:0071953 | elastic fiber(GO:0071953) |
| 4.9 | 14.7 | GO:0000801 | central element(GO:0000801) |
| 4.6 | 22.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 3.6 | 18.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 3.6 | 28.8 | GO:0005818 | aster(GO:0005818) |
| 3.6 | 10.8 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 3.5 | 17.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 3.2 | 16.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 3.0 | 21.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 2.8 | 16.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 2.7 | 11.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 2.7 | 32.0 | GO:0005687 | U4 snRNP(GO:0005687) |
| 2.6 | 7.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 2.5 | 17.3 | GO:0008278 | cohesin complex(GO:0008278) |
| 2.4 | 14.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 2.4 | 9.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 2.3 | 6.9 | GO:0071914 | prominosome(GO:0071914) |
| 2.3 | 9.2 | GO:0008623 | CHRAC(GO:0008623) |
| 2.3 | 18.2 | GO:0072687 | meiotic spindle(GO:0072687) |
| 2.2 | 37.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 2.1 | 19.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 2.1 | 6.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
| 2.0 | 18.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 2.0 | 5.9 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 1.9 | 5.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 1.9 | 5.8 | GO:0035101 | FACT complex(GO:0035101) |
| 1.9 | 1.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 1.8 | 5.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 1.8 | 12.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 1.8 | 11.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 1.8 | 10.7 | GO:0000125 | PCAF complex(GO:0000125) |
| 1.8 | 7.0 | GO:0060187 | cell pole(GO:0060187) |
| 1.8 | 3.5 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.7 | 5.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 1.7 | 17.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 1.6 | 4.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.6 | 6.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 1.6 | 15.8 | GO:0000796 | condensin complex(GO:0000796) |
| 1.5 | 15.2 | GO:0090543 | Flemming body(GO:0090543) |
| 1.5 | 16.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 1.5 | 18.1 | GO:0043219 | lateral loop(GO:0043219) |
| 1.5 | 36.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 1.5 | 4.5 | GO:0018444 | translation release factor complex(GO:0018444) |
| 1.5 | 17.7 | GO:0042555 | MCM complex(GO:0042555) |
| 1.5 | 84.1 | GO:0005871 | kinesin complex(GO:0005871) |
| 1.5 | 1.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 1.4 | 5.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 1.4 | 8.6 | GO:0098536 | deuterosome(GO:0098536) |
| 1.4 | 7.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 1.4 | 6.8 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 1.4 | 2.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 1.3 | 8.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 1.3 | 10.7 | GO:0097342 | ripoptosome(GO:0097342) |
| 1.3 | 10.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 1.3 | 68.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 1.3 | 6.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 1.2 | 3.7 | GO:1990423 | RZZ complex(GO:1990423) |
| 1.2 | 31.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 1.2 | 7.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 1.2 | 6.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 1.2 | 4.9 | GO:0035339 | SPOTS complex(GO:0035339) |
| 1.2 | 18.2 | GO:0031011 | Ino80 complex(GO:0031011) |
| 1.2 | 4.8 | GO:0032021 | NELF complex(GO:0032021) |
| 1.2 | 2.4 | GO:0097255 | R2TP complex(GO:0097255) |
| 1.2 | 7.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 1.2 | 18.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.1 | 10.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 1.1 | 9.1 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.1 | 10.0 | GO:0005688 | U6 snRNP(GO:0005688) |
| 1.1 | 81.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 1.1 | 7.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 1.1 | 3.2 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 1.1 | 2.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 1.0 | 11.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 1.0 | 13.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 1.0 | 6.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 1.0 | 6.1 | GO:0034448 | EGO complex(GO:0034448) |
| 1.0 | 1.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 1.0 | 7.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 1.0 | 2.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 1.0 | 7.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 1.0 | 1.9 | GO:0033010 | paranodal junction(GO:0033010) |
| 1.0 | 4.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 1.0 | 9.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 1.0 | 3.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 1.0 | 2.9 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.9 | 2.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.9 | 3.8 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.9 | 2.8 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.9 | 7.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.9 | 8.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.9 | 2.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.9 | 18.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.9 | 6.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.9 | 8.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 0.9 | 2.6 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.9 | 0.9 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.9 | 5.2 | GO:0070187 | telosome(GO:0070187) |
| 0.9 | 5.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.9 | 3.5 | GO:0031523 | Myb complex(GO:0031523) |
| 0.9 | 3.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.9 | 7.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.9 | 3.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.8 | 0.8 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.8 | 7.6 | GO:0089701 | U2AF(GO:0089701) |
| 0.8 | 3.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.8 | 2.5 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 0.8 | 0.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.8 | 9.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.8 | 10.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.8 | 2.4 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.8 | 2.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.8 | 4.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.8 | 4.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.8 | 1.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.8 | 8.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.8 | 4.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.8 | 2.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.8 | 6.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
| 0.8 | 1.5 | GO:0001652 | granular component(GO:0001652) |
| 0.8 | 1.5 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.8 | 6.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.8 | 5.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.7 | 2.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.7 | 6.4 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.7 | 6.4 | GO:0030478 | actin cap(GO:0030478) |
| 0.7 | 2.8 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.7 | 71.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.7 | 6.4 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.7 | 2.8 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.7 | 3.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.7 | 40.5 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.7 | 0.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.7 | 5.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.7 | 2.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.7 | 7.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.6 | 1.3 | GO:0097346 | Swr1 complex(GO:0000812) INO80-type complex(GO:0097346) |
| 0.6 | 0.6 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.6 | 6.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.6 | 1.9 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.6 | 9.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.6 | 6.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.6 | 9.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.6 | 19.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.6 | 9.4 | GO:0032039 | integrator complex(GO:0032039) |
| 0.6 | 8.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.6 | 5.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.6 | 1.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
| 0.6 | 0.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.6 | 1.7 | GO:0031417 | NatC complex(GO:0031417) |
| 0.6 | 41.0 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.6 | 8.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.6 | 3.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.6 | 2.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.6 | 5.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.6 | 10.5 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.6 | 2.2 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.5 | 7.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.5 | 6.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.5 | 2.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.5 | 1.6 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.5 | 7.5 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.5 | 3.7 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.5 | 3.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.5 | 12.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.5 | 3.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.5 | 0.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.5 | 22.7 | GO:0005657 | replication fork(GO:0005657) |
| 0.5 | 9.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.5 | 46.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.5 | 4.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.5 | 3.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.5 | 2.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.5 | 3.5 | GO:0038201 | TOR complex(GO:0038201) |
| 0.5 | 13.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.5 | 7.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.5 | 8.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.5 | 3.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.5 | 2.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.5 | 2.0 | GO:0071942 | XPC complex(GO:0071942) |
| 0.5 | 2.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.5 | 7.2 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.5 | 4.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.5 | 1.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.5 | 1.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.5 | 6.0 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.5 | 3.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.4 | 7.2 | GO:0051286 | cell tip(GO:0051286) |
| 0.4 | 3.5 | GO:0045095 | keratin filament(GO:0045095) |
| 0.4 | 4.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.4 | 2.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.4 | 2.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.4 | 4.3 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.4 | 4.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.4 | 2.9 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.4 | 3.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.4 | 5.7 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.4 | 5.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.4 | 5.2 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.4 | 4.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.4 | 9.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.4 | 1.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.4 | 3.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.4 | 9.3 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.4 | 22.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.4 | 15.5 | GO:0000791 | euchromatin(GO:0000791) |
| 0.4 | 1.1 | GO:1990047 | spindle matrix(GO:1990047) |
| 0.4 | 6.9 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.4 | 5.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.4 | 3.4 | GO:0042581 | specific granule(GO:0042581) |
| 0.4 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.4 | 11.2 | GO:0044391 | ribosomal subunit(GO:0044391) |
| 0.4 | 1.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.4 | 1.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.4 | 28.4 | GO:0005814 | centriole(GO:0005814) |
| 0.4 | 0.7 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.4 | 6.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.4 | 1.4 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.4 | 1.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.4 | 5.0 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.4 | 2.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 12.9 | GO:0097610 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
| 0.3 | 1.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.3 | 1.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.3 | 1.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.3 | 2.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.3 | 4.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.3 | 4.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.3 | 1.0 | GO:0031251 | PAN complex(GO:0031251) |
| 0.3 | 2.0 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.3 | 2.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.3 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.3 | 1.0 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
| 0.3 | 14.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.3 | 5.1 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.3 | 13.0 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.3 | 2.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 1.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.3 | 1.2 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.3 | 2.5 | GO:0000776 | kinetochore(GO:0000776) |
| 0.3 | 4.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.3 | 4.8 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.3 | 3.0 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.3 | 1.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.3 | 5.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.3 | 3.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.3 | 4.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.3 | 1.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.3 | 80.6 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.3 | 2.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.3 | 0.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.3 | 1.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.3 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.3 | 2.7 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.3 | 10.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.3 | 1.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.3 | 0.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.3 | 16.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.3 | 2.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 18.3 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.3 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
| 0.3 | 1.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.3 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.3 | 1.3 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.2 | 2.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.2 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.2 | 1.7 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 0.5 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.2 | 3.3 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.2 | 11.3 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.2 | 3.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 6.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.2 | 8.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.2 | 1.3 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.2 | 7.0 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.2 | 1.3 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.2 | 1.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.2 | 3.0 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.2 | 26.7 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.2 | 1.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.2 | 13.7 | GO:0005811 | lipid particle(GO:0005811) |
| 0.2 | 0.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.2 | 1.2 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.2 | 0.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.2 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 7.8 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.2 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.2 | 1.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.2 | 5.0 | GO:0016592 | mediator complex(GO:0016592) |
| 0.2 | 5.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.2 | 61.4 | GO:0000785 | chromatin(GO:0000785) |
| 0.2 | 6.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.2 | 1.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 1.8 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.2 | 1.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 28.2 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.2 | 7.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.2 | 1.4 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.2 | 0.2 | GO:0034708 | methyltransferase complex(GO:0034708) |
| 0.2 | 3.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
| 0.2 | 1.4 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
| 0.2 | 0.5 | GO:0002177 | manchette(GO:0002177) |
| 0.2 | 2.9 | GO:0015030 | Cajal body(GO:0015030) |
| 0.2 | 1.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 2.0 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.2 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 4.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.2 | 1.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.2 | 84.1 | GO:0005730 | nucleolus(GO:0005730) |
| 0.2 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.2 | 0.8 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.2 | 2.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 0.6 | GO:0005694 | chromosome(GO:0005694) |
| 0.1 | 0.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.1 | 2.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.1 | 1.1 | GO:0097223 | sperm part(GO:0097223) |
| 0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 4.6 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.1 | 0.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 2.0 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 2.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 1.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 1.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 2.3 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 1.4 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 1.7 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.1 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 1.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 3.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 1.0 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.6 | GO:0036452 | ESCRT III complex(GO:0000815) ESCRT complex(GO:0036452) |
| 0.1 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 6.0 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 12.3 | GO:0005813 | centrosome(GO:0005813) |
| 0.1 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
| 0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 2.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 288.9 | GO:0005634 | nucleus(GO:0005634) |
| 0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 0.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.1 | 0.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.0 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.0 | 0.2 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 0.0 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 0.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.0 | 0.3 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.0 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.0 | 0.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.3 | 27.9 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 5.0 | 30.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 4.0 | 15.8 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 3.9 | 11.7 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 3.8 | 19.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 3.7 | 11.0 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
| 3.5 | 48.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 3.5 | 10.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 3.2 | 28.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 3.2 | 12.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 3.1 | 15.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 3.1 | 15.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 3.1 | 9.2 | GO:0004335 | galactokinase activity(GO:0004335) |
| 2.9 | 22.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 2.9 | 8.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 2.8 | 8.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 2.8 | 14.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 2.8 | 27.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 2.8 | 5.6 | GO:0070990 | snRNP binding(GO:0070990) |
| 2.7 | 13.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 2.7 | 21.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 2.6 | 10.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 2.6 | 7.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 2.4 | 7.1 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
| 2.4 | 18.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 2.3 | 7.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 2.3 | 9.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 2.3 | 6.8 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 2.1 | 8.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 2.1 | 8.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 2.1 | 8.3 | GO:1990254 | keratin filament binding(GO:1990254) |
| 2.1 | 6.2 | GO:0032564 | dATP binding(GO:0032564) |
| 2.0 | 8.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 2.0 | 8.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 2.0 | 8.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 2.0 | 6.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 2.0 | 13.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 1.9 | 23.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 1.9 | 5.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
| 1.9 | 21.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 1.9 | 5.7 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 1.9 | 7.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 1.9 | 5.6 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 1.9 | 7.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 1.8 | 1.8 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 1.8 | 14.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 1.8 | 5.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 1.8 | 8.9 | GO:0043515 | kinetochore binding(GO:0043515) |
| 1.8 | 8.8 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
| 1.8 | 5.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 1.8 | 10.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 1.8 | 8.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 1.8 | 7.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 1.7 | 11.9 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 1.5 | 4.5 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 1.5 | 6.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 1.5 | 9.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 1.5 | 3.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 1.5 | 20.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 1.5 | 5.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 1.5 | 5.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 1.5 | 4.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 1.4 | 41.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 1.4 | 10.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 1.4 | 5.7 | GO:0042806 | fucose binding(GO:0042806) |
| 1.4 | 8.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 1.4 | 5.6 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 1.4 | 13.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 1.3 | 10.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 1.3 | 3.9 | GO:0051870 | methotrexate binding(GO:0051870) |
| 1.3 | 10.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 1.3 | 3.9 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 1.3 | 15.3 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.3 | 5.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 1.3 | 5.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.3 | 11.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 1.3 | 10.0 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 1.2 | 3.6 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
| 1.2 | 9.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 1.2 | 12.9 | GO:0008430 | selenium binding(GO:0008430) |
| 1.2 | 3.5 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 1.2 | 12.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 1.2 | 79.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 1.1 | 3.4 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 1.1 | 5.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 1.1 | 3.4 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
| 1.1 | 6.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 1.1 | 4.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 1.1 | 6.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 1.1 | 6.6 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.1 | 4.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 1.1 | 3.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 1.1 | 9.7 | GO:0035173 | histone kinase activity(GO:0035173) |
| 1.1 | 18.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 1.1 | 3.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 1.1 | 5.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 1.0 | 9.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 1.0 | 14.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 1.0 | 3.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 1.0 | 1.0 | GO:0031403 | lithium ion binding(GO:0031403) |
| 1.0 | 11.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 1.0 | 3.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 1.0 | 1.0 | GO:0070699 | activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
| 1.0 | 7.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 1.0 | 3.9 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
| 1.0 | 154.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 1.0 | 2.9 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.9 | 2.8 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.9 | 3.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.9 | 2.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.9 | 3.8 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.9 | 6.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.9 | 2.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
| 0.9 | 2.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.9 | 5.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.9 | 12.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.9 | 2.7 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 0.9 | 3.6 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.9 | 9.0 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.9 | 3.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.9 | 7.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.9 | 3.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.9 | 6.9 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.9 | 3.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.9 | 7.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.8 | 2.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
| 0.8 | 10.9 | GO:0031386 | protein tag(GO:0031386) |
| 0.8 | 2.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.8 | 13.8 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.8 | 8.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.8 | 3.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.8 | 1.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.8 | 7.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.8 | 0.8 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.8 | 3.2 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
| 0.8 | 14.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.8 | 3.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.8 | 18.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.8 | 0.8 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
| 0.8 | 3.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.8 | 7.0 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.8 | 10.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.8 | 1.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.8 | 1.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.8 | 2.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.7 | 7.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.7 | 3.0 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 0.7 | 3.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.7 | 6.6 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.7 | 28.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.7 | 7.8 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.7 | 2.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.7 | 3.5 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.7 | 7.0 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.7 | 32.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.7 | 2.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.7 | 6.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.7 | 4.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.7 | 3.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.7 | 4.7 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.7 | 2.0 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.7 | 7.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.7 | 29.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.7 | 1.3 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 0.7 | 2.6 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
| 0.6 | 4.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.6 | 4.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.6 | 5.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.6 | 5.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.6 | 3.8 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.6 | 3.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.6 | 2.5 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.6 | 4.3 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.6 | 4.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.6 | 3.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.6 | 4.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.6 | 2.5 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.6 | 3.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.6 | 2.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.6 | 7.8 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.6 | 3.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.6 | 3.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.6 | 6.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.6 | 1.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.6 | 7.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.6 | 1.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.6 | 2.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.6 | 4.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.6 | 2.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.6 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.6 | 1.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.6 | 0.6 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.6 | 2.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.6 | 4.0 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.6 | 2.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.6 | 8.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.6 | 37.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.6 | 2.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.6 | 2.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.6 | 1.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.6 | 4.5 | GO:0046790 | virion binding(GO:0046790) |
| 0.6 | 2.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.6 | 2.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.6 | 7.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.6 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.6 | 10.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.5 | 1.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.5 | 6.4 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.5 | 5.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.5 | 3.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.5 | 10.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.5 | 5.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.5 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.5 | 2.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.5 | 1.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.5 | 2.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.5 | 11.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.5 | 1.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.5 | 4.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.5 | 3.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.5 | 0.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.5 | 8.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.5 | 48.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.5 | 1.0 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.5 | 2.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.5 | 2.0 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.5 | 3.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.5 | 1.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.5 | 1.4 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.5 | 1.4 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.5 | 10.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.5 | 1.9 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.5 | 14.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.5 | 0.9 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.5 | 2.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.5 | 2.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.5 | 3.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.5 | 12.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.5 | 0.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.4 | 1.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.4 | 7.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.4 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.4 | 0.9 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.4 | 2.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.4 | 12.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.4 | 1.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.4 | 5.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.4 | 2.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.4 | 2.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.4 | 11.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.4 | 9.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.4 | 3.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.4 | 3.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.4 | 1.6 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.4 | 7.7 | GO:0070888 | E-box binding(GO:0070888) |
| 0.4 | 18.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.4 | 1.6 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 1.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.4 | 2.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.4 | 4.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.4 | 1.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.4 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.4 | 4.7 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.4 | 5.0 | GO:0048038 | quinone binding(GO:0048038) |
| 0.4 | 1.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.4 | 1.5 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.4 | 1.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.4 | 13.0 | GO:0034062 | RNA polymerase activity(GO:0034062) |
| 0.4 | 1.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.4 | 3.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.4 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.4 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.4 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
| 0.4 | 4.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.4 | 4.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.4 | 10.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.4 | 48.5 | GO:0004386 | helicase activity(GO:0004386) |
| 0.4 | 53.9 | GO:0042393 | histone binding(GO:0042393) |
| 0.4 | 107.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.4 | 16.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.4 | 2.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.4 | 0.7 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.4 | 2.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.4 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.4 | 6.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.4 | 15.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.3 | 5.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.3 | 3.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.3 | 11.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.3 | 1.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.3 | 12.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.3 | 2.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.3 | 1.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.3 | 4.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.3 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.3 | 1.6 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 0.3 | 3.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.3 | 1.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.3 | 4.5 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.3 | 1.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.3 | 1.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.3 | 1.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.3 | 1.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.3 | 0.6 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.3 | 19.7 | GO:0002039 | p53 binding(GO:0002039) |
| 0.3 | 1.9 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.3 | 1.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.3 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.3 | 1.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 0.3 | 0.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.3 | 3.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.3 | 3.3 | GO:0046977 | TAP binding(GO:0046977) |
| 0.3 | 7.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.3 | 8.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.3 | 0.6 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.3 | 2.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.3 | 3.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 1.8 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.3 | 6.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.3 | 1.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.3 | 2.9 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.3 | 0.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.3 | 2.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.3 | 0.8 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.3 | 1.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.3 | 5.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.3 | 3.0 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.3 | 2.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 1.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.3 | 1.4 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.3 | 17.0 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.3 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.3 | 4.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.3 | 1.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.3 | 0.8 | GO:0016405 | CoA-ligase activity(GO:0016405) |
| 0.3 | 3.4 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 0.8 | GO:0005118 | sevenless binding(GO:0005118) |
| 0.3 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.3 | 1.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.3 | 2.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.3 | 1.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.3 | 1.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.2 | 1.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.2 | 10.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 2.0 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.2 | 9.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.2 | 3.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.2 | 7.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 8.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.2 | 1.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.2 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.2 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.2 | 1.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.2 | 1.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.2 | 3.3 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.2 | 1.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.2 | 3.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.2 | 1.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.2 | 2.2 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.2 | 0.9 | GO:0034041 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
| 0.2 | 11.3 | GO:0001067 | regulatory region nucleic acid binding(GO:0001067) |
| 0.2 | 0.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.2 | 1.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 0.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.2 | 0.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.2 | 4.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 0.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.2 | 1.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.2 | 1.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.2 | 0.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.2 | 0.6 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.2 | 0.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.2 | 2.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.2 | 3.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.2 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 2.6 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
| 0.2 | 0.6 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.2 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.2 | 2.0 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.2 | 0.8 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
| 0.2 | 1.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.2 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.2 | 6.0 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.2 | 0.8 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
| 0.2 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 2.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
| 0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 1.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.2 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 1.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.2 | 17.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.2 | 2.0 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.2 | 7.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.2 | 1.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.2 | 2.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.2 | 0.9 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.2 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.2 | 1.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.2 | 1.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 0.6 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
| 0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 4.6 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.2 | 0.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.2 | 2.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.2 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
| 0.2 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.2 | 3.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.2 | 4.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.2 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 0.6 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.2 | 0.3 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.2 | 0.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.2 | 0.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.2 | 5.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.2 | 2.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 1.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 6.8 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 1.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 1.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.1 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.1 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.1 | 3.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 0.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 8.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
| 0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 0.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.1 | 2.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 1.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 1.1 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
| 0.1 | 4.8 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 13.7 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
| 0.1 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 2.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.1 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 0.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.1 | 1.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.1 | 0.2 | GO:0070404 | NADH binding(GO:0070404) |
| 0.1 | 3.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.1 | 3.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 1.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 0.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.6 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.1 | 1.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 1.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 1.0 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 6.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.1 | 0.3 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 10.6 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.1 | 1.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 6.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.1 | 2.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.1 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.1 | 2.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.1 | 0.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 5.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 1.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 0.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.1 | 1.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 2.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.1 | 1.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 0.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.1 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.1 | 3.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 1.7 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 2.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.1 | 2.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.1 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 1.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 0.2 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.1 | 2.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.1 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 0.2 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
| 0.1 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 0.2 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.1 | 0.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.1 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.1 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.1 | 0.3 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 0.6 | GO:0043531 | ADP binding(GO:0043531) |
| 0.1 | 0.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.1 | 1.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 2.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 1.1 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.1 | 0.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 12.2 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 0.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 1.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.1 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
| 0.0 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.0 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.0 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.1 | GO:0004454 | ketohexokinase activity(GO:0004454) |
| 0.0 | 0.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.0 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 0.0 | 0.9 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
| 0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 0.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
| 0.0 | 7.3 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 0.0 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.0 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.0 | 4.0 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.0 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.2 | GO:0019840 | isoprenoid binding(GO:0019840) |
| 0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.0 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.0 | 2.2 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
| 0.0 | 6.4 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
| 0.0 | 0.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
| 0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.0 | 0.1 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
| 0.0 | 0.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.0 | 9.5 | GO:0003723 | RNA binding(GO:0003723) |
| 0.0 | 0.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 101.7 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 1.8 | 64.7 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 1.4 | 64.9 | PID_ATR_PATHWAY | ATR signaling pathway |
| 1.3 | 55.8 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 1.2 | 2.5 | PID_IL3_PATHWAY | IL3-mediated signaling events |
| 1.0 | 26.0 | PID_MYC_PATHWAY | C-MYC pathway |
| 1.0 | 37.2 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 1.0 | 20.0 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
| 0.9 | 6.9 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.7 | 13.8 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
| 0.7 | 6.4 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.7 | 38.4 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.7 | 19.6 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
| 0.7 | 11.8 | PID_IL23_PATHWAY | IL23-mediated signaling events |
| 0.6 | 39.0 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.6 | 18.0 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.6 | 4.2 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 0.6 | 33.2 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 0.6 | 2.9 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.5 | 10.4 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.5 | 2.9 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.5 | 7.0 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.5 | 3.7 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.5 | 9.0 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.5 | 4.1 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.4 | 3.6 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.4 | 10.8 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.4 | 12.6 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.4 | 36.6 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.4 | 10.3 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
| 0.4 | 2.3 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.4 | 5.7 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.4 | 3.7 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.4 | 5.0 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.3 | 20.0 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.3 | 1.0 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 9.1 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.3 | 21.9 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.3 | 11.0 | PID_CDC42_PATHWAY | CDC42 signaling events |
| 0.3 | 9.4 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 12.4 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.3 | 8.2 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.3 | 8.9 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.3 | 1.6 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.3 | 7.3 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.2 | 0.5 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.2 | 8.5 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.2 | 5.1 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.2 | 2.6 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.2 | 3.0 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
| 0.2 | 0.2 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.2 | 3.5 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 0.7 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 7.4 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
| 0.2 | 4.7 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 0.2 | 5.8 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 2.4 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.2 | 3.6 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.2 | 2.0 | ST_ADRENERGIC | Adrenergic Pathway |
| 0.2 | 1.8 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 11.4 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 5.5 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.2 | 4.6 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
| 0.2 | 4.9 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.2 | 4.4 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.2 | 1.8 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.2 | 3.3 | ST_B_CELL_ANTIGEN_RECEPTOR | B Cell Antigen Receptor |
| 0.2 | 2.3 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 2.1 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
| 0.2 | 4.2 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 2.9 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 1.5 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 2.0 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 1.3 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.1 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 0.4 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.1 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 1.6 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 0.6 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 1.0 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 0.7 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
| 0.1 | 2.1 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 12.8 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 0.8 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 0.5 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 2.8 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 0.1 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 2.4 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 1.1 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.1 | 2.2 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.1 | 8.4 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 0.5 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.1 | 1.1 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.0 | 2.0 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.7 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.3 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.7 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.6 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.7 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.1 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.4 | PID_P53_REGULATION_PATHWAY | p53 pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 3.3 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 3.0 | 81.0 | REACTOME_KINESINS | Genes involved in Kinesins |
| 3.0 | 47.8 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 2.5 | 30.5 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 2.5 | 57.4 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 2.0 | 18.1 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 1.8 | 14.1 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 1.7 | 36.3 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 1.7 | 1.7 | REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 1.7 | 31.7 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 1.7 | 14.9 | REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 1.6 | 22.3 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 1.6 | 83.5 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 1.4 | 16.8 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
| 1.4 | 1.4 | REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 1.3 | 10.6 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 1.3 | 14.2 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 1.3 | 12.9 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.3 | 71.9 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 1.2 | 14.6 | REACTOME_DNA_STRAND_ELONGATION | Genes involved in DNA strand elongation |
| 1.2 | 7.2 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 1.2 | 66.3 | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 1.2 | 27.2 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 1.2 | 16.5 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 1.2 | 77.3 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 1.1 | 12.3 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 1.1 | 21.2 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 1.1 | 9.5 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 1.1 | 11.6 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
| 1.0 | 6.1 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 1.0 | 10.6 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 1.0 | 30.8 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
| 0.9 | 15.8 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.9 | 4.4 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.9 | 1.7 | REACTOME_CELL_CYCLE_CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
| 0.8 | 0.8 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.8 | 25.9 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.8 | 7.1 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.8 | 6.2 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.8 | 3.1 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 0.7 | 8.1 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.7 | 2.9 | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.7 | 6.5 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.7 | 5.0 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.7 | 19.3 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.7 | 4.2 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.7 | 7.4 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.7 | 5.9 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
| 0.6 | 8.9 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.6 | 51.3 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.6 | 3.8 | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.6 | 11.2 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.6 | 68.7 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
| 0.6 | 8.9 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.6 | 15.7 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.6 | 6.3 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.6 | 42.2 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.6 | 11.2 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.5 | 3.3 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.5 | 11.0 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.5 | 11.8 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.5 | 9.5 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.5 | 12.4 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.5 | 4.0 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.5 | 6.9 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.5 | 0.5 | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.5 | 8.6 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.5 | 3.8 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.5 | 1.4 | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.5 | 5.0 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.5 | 8.7 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.5 | 1.8 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.4 | 0.4 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.4 | 0.9 | REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.4 | 6.1 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
| 0.4 | 7.4 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.4 | 6.8 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.4 | 4.6 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.4 | 3.7 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.4 | 0.7 | REACTOME_BASE_EXCISION_REPAIR | Genes involved in Base Excision Repair |
| 0.4 | 1.1 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.4 | 2.1 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.4 | 6.0 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.3 | 3.0 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.3 | 2.3 | REACTOME_TELOMERE_MAINTENANCE | Genes involved in Telomere Maintenance |
| 0.3 | 0.6 | REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.3 | 4.0 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.3 | 8.1 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.3 | 2.3 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.3 | 1.2 | REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.3 | 17.7 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.3 | 3.7 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.3 | 0.8 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.3 | 1.3 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.3 | 7.5 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.3 | 14.3 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.3 | 11.3 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.3 | 1.5 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.3 | 7.3 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.2 | 2.2 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 6.6 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
| 0.2 | 6.9 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 4.1 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
| 0.2 | 2.6 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 2.3 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 36.4 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.2 | 0.6 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.2 | 4.2 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 5.5 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.2 | 4.3 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 2.6 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.2 | 4.2 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.2 | 19.8 | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.2 | 1.1 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.2 | 1.9 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 2.6 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 2.4 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.2 | 5.7 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 9.8 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 0.6 | REACTOME_TCR_SIGNALING | Genes involved in TCR signaling |
| 0.1 | 1.1 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 4.3 | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.1 | 0.4 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 1.6 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 7.8 | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.1 | 0.8 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 1.1 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 0.3 | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 0.4 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 1.2 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 0.8 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 1.4 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 0.6 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 5.3 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 0.6 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 0.2 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.1 | 2.5 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 0.5 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 1.0 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 5.9 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 0.8 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.7 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
| 0.0 | 0.1 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.0 | 0.4 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 1.7 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.0 | 0.2 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.0 | 0.3 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 0.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.0 | 0.8 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 1.3 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 3.1 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.1 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.0 | 0.4 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.7 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 1.3 | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.0 | 0.3 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.3 | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.0 | 0.3 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.2 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
|
|
|